MedTrace Logo

Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B

NCT01342185 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2012-10-18

No results posted yet for this study

Summary

The purpose of this study is to verify the effectiveness and safety of medical ozone therapy system in treatment of chronic hepatitis B.

Conditions

Interventions

DEVICE

medical ozone therapy with tianyi

Medical ozone therapy with instrument made in China Patients in this arm will receive autohemotherapy. First month: ozone concentration: 20µg \~40µg /ml;The second month: 30µg/ml × 100ml oxygen- ozone gas × 100 ml blood;The third month: 20µg/ml × 100ml oxygen- ozone gas× 100 ml blood.

DEVICE

medical ozone therapy with humares

Medical ozone therapy with instrument made in Germany Patients in this group will receive autohemotherapy treatment, regime as ArmⅠ.

DRUG

Diammonium glycyrrhizinate Capsules

Drug: Diammonium glycyrrhizinate Capsules Patients in this group will receive oral Diammonium glycyrrhizinate Capsules 150mg, three times a day for 12 weeks.

Sponsors & Collaborators

  • Tianyi medical instruments limited company, Ningbo, China

    collaborator UNKNOWN

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • yabing guo, professor · Nanfang Hospital, Southern Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01342185 on ClinicalTrials.gov